Welcome to our dedicated page for Bankwell Financial Group SEC filings (Ticker: BWFG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Bankwell Financial Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Bankwell Financial Group's regulatory disclosures and financial reporting.
Lawrence B. Seidman, a director of Bankwell Financial Group, Inc. (BWFG), reported multiple transactions on 09/12/2025. The filing shows purchases totaling 17,000 common shares across six entities at prices between $45.91 and $45.93 per share. The report also records dispositions of 19,405 shares associated with restricted stock vesting and a deferred compensation plan. Aggregating the transactions, the report shows a net decrease of 2,405 shares on that date across the reporting person’s holdings.
The record lists the beneficial ownership balances for each reporting entity after the purchases (for example, 194,509, 133,370, 172,234, 114,199, 129,711, and 21,419 shares). Explanatory notes specify the restricted stock grants, vesting schedules, and the number of shares vested as of the filing date.
Lawrence B. Seidman, a director of Bankwell Financial Group, Inc. (BWFG), reported multiple transactions on 09/10/2025. He purchased blocks of common stock through several affiliated entities: 4,602 shares at $44.53, 1,502 shares at $44.54, 913 shares at $44.55, 2,700 shares at $44.54, 753 shares at $44.55 and 530 shares at $44.57; the Form shows the resulting beneficial ownership counts for each entity after those purchases. The filing also reports disposals tied to restricted stock vesting and a deferred compensation plan: 1,800 shares (granted 02/07/2025) with staged vesting through 2028, 1,067 shares (granted 12/29/2023) with 533 already vested, 800 shares (granted 12/30/2022) with 800 vested, 400 shares (granted 12/31/2021) with 1,200 vested to date, and a separate 15,338-share disposition related to a Deferred Compensation Plan. The Form 4 was signed by an attorney-in-fact on 09/11/2025.
Blake S. Drexler, a director of Bankwell Financial Group, Inc. (BWFG), reported multiple changes in his beneficial ownership on a Form 4 filed for transactions dated 09/04/2025. The filing shows a purchase of 170 shares of common stock at $42.45 per share. It also reports several dispositions from various accounts and awards, including 1,200 shares disposed from a deferred compensation plan, 1,067 shares and 800 shares disposed under other listed entries, and 158,928 shares disposed associated with an IRA-401(k) entry. The filing lists indirect beneficial ownership positions (for example 36,649 shares and 58,224 shares) and describes restricted stock grants from 2021–2025 with vesting schedules and amounts in the explanations.
Jeffrey R. Dunne, a director of Bankwell Financial Group, Inc. (BWFG), reported insider transactions on 09/04/2025. The filing shows a purchase of 407 shares of common stock at $42.45 per share, recorded with transaction code P. After the reported transactions, the filing lists 5,085 shares beneficially owned indirectly. The Form 4 also documents restricted stock grants described in the explanations: an 1,800-share grant dated February 7, 2025, vesting in three annual tranches of 600 shares, and a 1,600-share grant dated December 29, 2023, of which 533 shares vested on February 7, 2025 and the remaining vest over 2026–2027. The filing is signed by an attorney-in-fact on 09/05/2025.
Carl M. Porto, a director of Bankwell Financial Group, Inc. (BWFG), reported an insider purchase and several dispositions on this Form 4. The filing shows a purchase of 506 shares of common stock on 09/04/2025 at $42.45 per share, recorded with transaction code "P." After the reported transactions, the filing lists 20,837 shares beneficially owned (reported as indirect ownership). The form also records dispositions: 1,800 shares, 1,067 shares, 800 shares, 400 shares and a separate line showing 20,465 shares disposed to a Law Firm Pension Plan. The filing is signed by Angelo G. Fusaro as attorney-in-fact for Mr. Porto.
Eric J. Dale, a director of Bankwell Financial Group, Inc. (BWFG), purchased 819 shares of common stock on 09/04/2025 at $42.45 per share and, after the transaction, beneficially owns 40,550 shares indirectly through a deferred compensation plan. The Form 4 also reports dispositions of restricted shares: 1,800 shares from a February 7, 2025 grant (vesting schedule noted), 1,067 shares from a December 29, 2023 grant (533 vested as of filing), 800 shares from a December 30, 2022 grant (800 vested as of filing), and 400 shares from a December 31, 2021 grant (1,200 vested as of filing). The filing was signed by an attorney-in-fact on 09/05/2025.
Lawrence B. Seidman, a director of Bankwell Financial Group, Inc. (BWFG), reported purchases and vesting-related ownership changes. On 09/04/2025 he acquired 448 shares of common stock at $42.45. On 09/05/2025 he acquired 180 shares at $42.53 under a deferred compensation plan. The filing lists multiple indirect holdings through affiliated entities and partnerships totaling large positions across Seidman-controlled vehicles. Several grants of restricted stock from 2021–2025 are described with scheduled vesting: portions of 1,800; 1,600; 1,600; and 1,600 share awards vesting on specified future anniversaries and some portions already vested.
Bankwell Financial Group, Inc. (BWFG) submitted a Form 144 notice reporting a proposed sale of common stock. The filing identifies a broker, Georgeson Securities Corp., and lists 245 shares of common stock with an aggregate market value of $10,177.30 intended for sale approximately on 09/02/2025 on NASDAQ. The securities were acquired through restricted stock vesting on 08/31/2025 and are described as compensation. The filing reports 7,877,443 shares outstanding for the issuer and indicates no sales in the prior three months. The filer attests there is no undisclosed material adverse information.
Steven H. Brunner, EVP & Chief Risk Officer of Bankwell Financial Group, Inc. (BWFG), reported transactions on 09/02/2025. He sold 245 shares through a company cashless exercise to cover taxes from vesting 666 shares at reported sale prices between $41.54 and $41.56. Following the reported transactions, he beneficially owned 1,969 shares. The filing also details multiple equity awards granted under the 2022 Stock Plan: 1,493 shares (mix of restricted and performance shares), 249 performance shares, 498 performance shares, 4,894 shares (restricted and performance, with 816 vested and 542 performance shares forfeited), 1,604 restricted shares (1,068 vested), and 1,603 performance shares (535 vested and 535 forfeited).
Todd Lampert, a director of Bankwell Financial Group, Inc. (BWFG), reported multiple transactions and holdings. He sold 2,000 shares on 08/27/2025 at reported sale prices in the $42.52–$43.51 range and sold 3,300 shares on 08/28/2025 at reported sale prices in the $42.40–$43.40 range, reducing his direct beneficial ownership from 16,833 shares to 13,533 shares after those sales. The filing also reports several disposals and restricted stock grants: 400, 1,800, 1,600, 1,600 and 1,600 shares described with varying vesting schedules and vesting status. Indirect holdings include 9,699 shares in a spouse's IRA and 8,608 shares in an IRA. The form is signed by Mr. Lampert on 08/29/2025.